https://www.ajmc.com/newsroom/fda-approves-revefenacin-a-onceaday-nebulized-lama-for-copdFDA Approves Revefenacin, a Once-a-Day Nebulized LAMA, for COPD
Approvals
Theravance Biopharma and Mylan Receive FDA Approval for YUPELRI™ (revefenacin) in Adults with Chronic Obstructive Pulmonary Disease
https://www.prnewswire.com/news-releases/theravance-biopharma-and-mylan-receive-fda-approval-for-yupelri-revefenacin-in-adults-with-chronic-obstructive-pulmonary-disease-300747672.html
FDA approves novel device for treating breathing difficulty from severe emphysema
FDA approves novel device for treating breathing difficulty from severe emphysema https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm612271.htm
